BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

EYLEA now approved to treat five retinal conditions caused by ocular angiogenesis

ROP is a leading cause of childhood blindness worldwide Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug...

February 09, 2023 | News

Nectin Therapeutics to Collaborate with Merck on a Clinical Trial of Anti-PVR Antibody NTX1088

Nectin Therapeutics Ltd. (Nectin), a biotechnology company developing novel targeted immunotherapies that address resistance to approved immune oncology tr...

February 08, 2023 | News

Psychedelic-Assisted Therapies Allowed in Australia Through Special Access Scheme

As the funder and sponsor of the most advanced research of a psychedelic-assisted therapy, MAPS is encouraged to see a fourth nation provide access to some...

February 06, 2023 | News

GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer

Combined with other clinical risk factors the test provides a comprehensive risk assessment in a simple saliva test. Highlights: New test integ...

February 03, 2023 | News

TransCure bioServices offers BioVolume 3D imaging for insightful preclinical oncology research

TransCure bioServices adds BioVolume 3D imaging to its service offerings, enabling them to deliver even higher quality tumor growth results to customers. W...

February 02, 2023 | News

Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short

The 2022 G-FINDER Report, released today, reveals that for the year 2021, global funding for the development of critical new health technologies to overcom...

February 01, 2023 | News

SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane

First Generic of Abraxane in Korea, World 4th Commercial Scale-Up Global tech-transfer expected to US, Japan, and Europe Through this contr...

January 26, 2023 | News

KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced it entered into a subcontract with Mapp Biopharmaceutical, Inc. (Mapp) for the cont...

January 23, 2023 | News

Thermo Fisher Scientific Launches CE-IVD Marked Assay to Detect Treatment-Resistant Strains of HIV-1

Data derived from the test can help to serve as a critical tool to monitor and help treat HIV-1-infected individuals, as well as inform epidemiologic and g...

January 23, 2023 | News

CureSearch To Lead Impact Study On Cost, Treatment Benefits Of Molecular Testing For Childhood Cancer Patients

Cancer is the number one disease killer in children in the US. Although survival rates for the most common types of childhood cancer have greatly increased...

January 20, 2023 | News

NUS Medicine establishes the Lim Wee Chai Visiting Professorship in Medicine with gift of S$1 million

The signing ceremony cum cheque presentation between Professor Chong Yap Seng, Dean of NUS Medicine, and Tan Sri Dr. Lim Wee Chai, was held on 10 January 2...

January 13, 2023 | News

Research commenced with Keio University to discover drugs using "Chemicals Informatics

Hitachi High-Tech Solutions Corporation, in collaboration with Keio University Faculty of Pharmacy, Department of Pharmaceutical Sciences is commenci...

January 12, 2023 | News

EpiVax and Zoetis to Collaborate on Swine T cell Epitope Prediction Tool: CircoMatch™

The new tool provides a quick turnaround, powerful way to provide near real-time predictive effectiveness data so swine veterinarians and producers can mak...

January 11, 2023 | News

Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer

Exelixis is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization o...

January 11, 2023 | News

Stay Connected